U.S., March 10 -- ClinicalTrials.gov registry received information related to the study (NCT07458815) titled 'Vitamin D for Acute Intracerebral Hemorrhage' on March 03.
Brief Summary: Intracerebral hemorrhage (ICH) is the most deadly and debilitating form of stroke. To date, effective treatment that could improve the functional outcome of ICH remained elusive. In a mice model of ICH, it was demonstrated that high dose Vitamin D (VitD) treatment enhanced hematoma resolution by promoting reparative macrophage differentiation and improved neurobehavioral performance in mice. Hence, this pilot study aimed to investigate the feasibility and safety of VitD treatment for ICH in human subjects.
VICToHR is a prospective, randomized, open-label, bl...